Inhibition of hepatitis B virus replication by adenine arabinoside monophosphate coupled to lactosaminated albumin. Efficacy and minimal active dose.
Torrani Cerenzia
M R
MR
Fiume
L
L
Busi
C
C
Mattioli
A
A
Di Stefano
G
G
Gervasi
G B
GB
Brunetto
M R
MR
Piantino
P
P
Verme
G
G
Bonino
F
F
D000328:Adult; D000368:Aged; D002908:Chronic Disease; D005260:Female; D006509:Hepatitis B / Q000188:drug therapy; D006515:Hepatitis B virus / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D012709:Serum Albumin / Q000494:pharmacology* / Q000627:therapeutic use; D001084:Vidarabine Phosphate / Q000494:pharmacology* / Q000627:therapeutic use; D014779:Virus Replication / Q000187:drug effects*
D012709:Serum Albumin; C046912:lactosaminated serum albumin; D001084:Vidarabine Phosphate